Health Care [ 6/12 ] | Biotechnology [ 32/73 ]
NASDAQ | Common Stock
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules.
The company is based in Santa Barbara, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 13, 25 | -2.75 Decreased by -618.83% | - |
| Mar 31, 25 | -0.24 Increased by +25.89% | - |
| Nov 12, 24 | -0.14 Increased by +49.34% | - |
| Aug 14, 24 | -0.36 Decreased by -117.44% | - |
| May 15, 24 | -0.38 Decreased by -175.07% | - |
| Nov 14, 23 | -0.32 Decreased by -502.80% | - |
| Aug 14, 23 | -0.28 Decreased by -598.25% | - |
| May 15, 23 | -0.17 Increased by +94.04% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 25 | 0.00 Decreased by -100.00% | -1.44 M Increased by +16.47% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | -25.14 K Decreased by N/A% | -1.55 M Increased by +7.29% | Increased by +6.18 K% Decreased by N/A% |
| Sep 30, 24 | 25.14 K Increased by +N/A% | -641.00 K Increased by +54.12% | Decreased by -2.55 K% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -1.61 M Decreased by -32.81% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 3.20 K Increased by +N/A% | -1.72 M Decreased by -140.11% | Decreased by -53.88 K% Decreased by N/A% |
| Dec 31, 23 | 0.00 Decreased by N/A% | -1.68 M Decreased by -176.14% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | -1.40 M Decreased by -56.09% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -1.21 M Decreased by -81.41% | Decreased by N/A% Decreased by N/A% |